Author

Jerry A. Katzmann

Observed names: J A Katzmann, J Katzmann, J.A. Katzmann, JERRY A. KATZMANN, JERRY KATZMANN, Jerry A Katzmann, Jerry A. Katzmann, PhD, Jerry Katzmann

Institution: Mayo Clinic

Observed institutions: University of Vermont, University of Iowa, Mayo Clinic, The University of Texas at San Antonio Health Science Center, University of Pavia, Resurrection Medical Center, National Cancer Institute, Peking University Third Hospital, Center for Cancer Research, Division of Cancer Epidemiology and Genetics, University of Birmingham

OpenAlex ID: A5111767341

Prevalence of Monoclonal Gammopathy of Undetermined Significance

2006 · Robert A. Kyle, Terry M. Therneau, et al. · New England Journal of Medicine · 1,427

PDF

Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study

2009 · Ola Landgren, Robert A. Kyle, et al. · Blood · 1,128

Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance

2005 · S. Vincent Rajkumar, Robert A. Kyle, et al. · Blood · 702

PDF

Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.

2002 · Jerry A Katzmann, Raynell J Clark, et al. · PubMed · 620

Serum Reference Intervals and Diagnostic Ranges for Free κ and Free λ Immunoglobulin Light Chains: Relative Sensitivity for Detection of Monoclonal Light Chains

2002 · Jerry A Katzmann, Raynell J Clark, et al. · Clinical Chemistry · 620

Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma

2007 · Angela Dispenzieri, Robert A. Kyle, et al. · Blood · 433

Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study

2010 · Angela Dispenzieri, Jerry A Katzmann, et al. · The Lancet · 394

Screening Panels for Detection of Monoclonal Gammopathies

2009 · Jerry A Katzmann, Robert A Kyle, et al. · Clinical Chemistry · 348

PDF

Diagnostic Performance of Quantitative κ and λ Free Light Chain Assays in Clinical Practice

2005 · Jerry A Katzmann, Roshini S Abraham, et al. · Clinical Chemistry · 265

Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation

2006 · Angela Dispenzieri, Martha Q. Lacy, et al. · Blood · 253

Concurrent Assays of Circulating Bone Gla-Protein and Bone Alkaline Phosphatase: Effects of Sex, Age, and Metabolic Bone Disease*

1988 · RALPH J. DUDA, JOHN F. O’BRIEN, et al. · The Journal of Clinical Endocrinology & Metabolism · 248

Elimination of the Need for Urine Studies in the Screening Algorithm for Monoclonal Gammopathies by Using Serum Immunofixation and Free Light Chain Assays

2006 · Jerry A. Katzmann, Angela Dispenzieri, et al. · Mayo Clinic Proceedings · 215

Disease Associations With Monoclonal Gammopathy of Undetermined Significance: A Population-Based Study of 17,398 Patients

2009 · John P. Bida, Robert A. Kyle, et al. · Mayo Clinic Proceedings · 202

PDF

The clinical aspects of biclonal gammopathies

1981 · Robert A. Kyle, Robert A. Robinson, et al. · The American Journal of Medicine · 200

Prevalence of Monoclonal Gammopathy of Undetermined Significance Among Men in Ghana

2007 · Ola Landgren, Jerry A. Katzmann, et al. · Mayo Clinic Proceedings · 194

Quantitative Analysis of Serum Free Light Chains

2003 · Roshini S. Abraham, Jerry A. Katzmann, et al. · American Journal of Clinical Pathology · 189

Comprehensive Assessment of M-Proteins Using Nanobody Enrichment Coupled to MALDI-TOF Mass Spectrometry

2016 · John R Mills, Mindy C Kohlhagen, et al. · Clinical Chemistry · 182

Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical features

2010 · Shaji Kumar, Angela Dispenzieri, et al. · Blood · 178

Immunoglobulin free light chains and solitary plasmacytoma of bone

2006 · David Dingli, Robert A. Kyle, et al. · Blood · 176

Supratentorial pilocytic astrocytomas. A clinicopathologic, prognostic, and flow cytometric study of 51 patients

1993 · Peter A. Forsyth, Edward G. Shaw, et al. · Cancer · 173

PDF

Subependymal Giant Cell Astrocytoma: A Clinical, Pathological, and Flow Cytometric Study

1991 · Charles W. Shepherd, Bernd W. Scheithauer, et al. · Neurosurgery · 170

Using Mass Spectrometry to Monitor Monoclonal Immunoglobulins in Patients with a Monoclonal Gammopathy

2014 · David R. Barnidge, Surendra Dasari, et al. · Journal of Proteome Research · 167

Pesticide exposure and risk of monoclonal gammopathy of undetermined significance in the Agricultural Health Study

2009 · Ola Landgren, Robert A. Kyle, et al. · Blood · 167

Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women

2010 · Ola Landgren, S. Vincent Rajkumar, et al. · Blood · 162

Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance

2009 · Celine M. Vachon, Robert A. Kyle, et al. · Blood · 152

Works count: 213

Citation count: 15,620

H-index: 63

I10-index: 151